Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...

Genotropin (somatropin) is a brand-name drug that’s prescribed for growth hormone deficiency in adults and growth failure in certain children. Genotropin comes as a powder that’s mixed with liquid and ...

Children with growth disturbance could be offered a new weekly treatment as an alternative to daily injections. The National Institute for Health and Care Excellence (NICE) has recommended somatrogon ...

Five people appear to have developed Alzheimer’s disease after receiving growth hormones from deceased donors’ brains as children. Although based on a small group of people, this suggests that the ...

Genotropin (somatropin) is a brand-name injectable solution used for growth problems in certain adults and children. As with other drugs, Genotropin can cause side effects, such as injection site ...

WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...

Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...

Pfizer disclosed the regulatory action late Friday. FDA complete response letters are not public documents, and the company did not say what concerns or questions were raised by the agency about the ...

Add Yahoo as a preferred source to see more of our stories on Google. Chinese health experts are raising concerns about the growing interest among parents to use synthetic human growth hormones on ...